Please use this identifier to cite or link to this item: https://doi.org/10.1007/s10120-020-01151-8
Title: Combined inhibition of PD-1/PD-L1, Lag-3, and Tim-3 axes augments antitumor immunity in gastric cancer–T cell coculture models
Authors: Mimura, Kosaku
Kua, Ley-Fang 
Xiao, Jin-Fen 
Asuncion, Bernadette Reyna
Nakayama, Yuko
Syn, Nicholas
Fazreen, Zul
Soong, Richie 
Kono, Koji
Yong, Wei-Peng 
Keywords: Combinatorial immunotherapy
Gastric cancer
Lag-3
PD-1
Tim-3
Issue Date: 20-Feb-2021
Publisher: Springer Japan
Citation: Mimura, Kosaku, Kua, Ley-Fang, Xiao, Jin-Fen, Asuncion, Bernadette Reyna, Nakayama, Yuko, Syn, Nicholas, Fazreen, Zul, Soong, Richie, Kono, Koji, Yong, Wei-Peng (2021-02-20). Combined inhibition of PD-1/PD-L1, Lag-3, and Tim-3 axes augments antitumor immunity in gastric cancer–T cell coculture models. Gastric Cancer 24 (3) : 611-623. ScholarBank@NUS Repository. https://doi.org/10.1007/s10120-020-01151-8
Rights: Attribution 4.0 International
Abstract: Background: Immunotherapy targeting PD-1 provides a limited survival benefit in patients with unresectable advanced or recurrent gastric cancer (GC). Beside PD-L1, the expression of inhibitory ligands such as CEACAM-1 and LSECtin on GC cells account for this limitation. Here we assessed their expression and immune suppressive effect in GC patients. Methods: Using multiplexed immunohistochemistry staining, we evaluated the distribution of different inhibitory ligands, including PD-L1, CEACAM-1, LSECtin, and MHC class II, in 365 GC patients. We analyzed their correlations and overall survival (OS) based on the expression of each inhibitory ligand and the independent prognostic factors that affect OS. Subsequently, we evaluated the additive effect of anti-PD-1 mAb or anti-PD-L1 mAb with/without anti-Lag-3 mAb with/without anti-Tim-3 mAb in cytotoxic assay using tumor-antigen specific CTL clones against GC cell lines. Results: Co-expression of the inhibitory ligands for PD-1, Tim-3, and Lag-3 was observed in the largest proportion (34.7%). CEACAM-1, LSECtin, and MHC class II expression showed significant correlation with PD-L1 expression and OS. Multivariable analysis demonstrated that CEACAM-1 low is an independent prognostic factor. Furthermore, combining dual and triple ICIs yielded additive effect on cytotoxicity of CTL clones against each immune inhibitory ligand positive GC cell lines. Conclusions: Our findings suggested that the expression of inhibitory ligands for Tim-3 and Lag-3 on GC cells serve as potential biomarkers to predict the response to anti-PD-1 therapy and the combinatorial immunotherapy with ICIs targeting for PD-1, Tim-3, and Lag-3 has a therapeutic potential for GC patients. © 2021, The Author(s).
Source Title: Gastric Cancer
URI: https://scholarbank.nus.edu.sg/handle/10635/233319
ISSN: 1436-3291
DOI: 10.1007/s10120-020-01151-8
Rights: Attribution 4.0 International
Appears in Collections:Staff Publications
Elements

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1007_s10120-020-01151-8.pdf4.19 MBAdobe PDF

OPEN

NoneView/Download

SCOPUSTM   
Citations

18
checked on Jan 22, 2023

Page view(s)

18
checked on Jan 26, 2023

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons